Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18

Immunology

Volumn 102, Issue 2, 2001, Pages 234-241

  Kim, S H ^a   Cho, D ^b   Kim, T S ^a  

^a Chonnam National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; GAMMA INTERFERON; INTERLEUKIN 18; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; FEMALE; GENE THERAPY; HOST RESISTANCE; IMMUNIZATION; IN VIVO STUDY; LUNG INFECTION; MOLECULAR CLONING; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL VACCINES; DNA, COMPLEMENTARY; FEMALE; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-18; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS; TRANSFECTION; VACCINES, DNA;

EID: 0035102894     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01150.x     Document Type: Article

References (48)

1. Impact of opportunistic disease on survival in patients with HIV infection
2. Disseminated tuberculosis in interferon-γ gene-disrupted mice
3. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection
4. A novel costimulatory factor for γ interferon induction found in the livers of mice causes endotoxic shock
5. Cloning of a new cytokine that induces IFN-γ production by T cells
6. Interleukin-18: Biological properties and clinical implications
7. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
8. Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection
9. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
10. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice
11. Interleukin-10: Potential benefits and possible risks in clinical infectious diseases
12. Cytokine combinations: Therapeutic use in patients with advanced renal cell carcinoma
13. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans
14. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration
15. DNA vaccines
16. Modulating the immune response to genetic immunization
17. Systemic immunological effects of cytokine genes injected into skeletal muscle
18. Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18)
19. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens
20. Do DNA vaccines induce autoimmune disease?
21. Developing recombinant and synthetic vaccines for the treatment of melanoma
22. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
23. Induction of antigen-specific cytotoxic T lymphocytes in humans by malaria DNA vaccines
24. Depletion of B cells in vivo by chimeric mouse human monoclonal antibody to CD20
25. Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex
26. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection
27. Immunization of mice with allogeneic fibroblasts genetically modified for interleukin-2-secretion and expression of melanoma-associated antigens stimulates predetermined classes of antimelanoma effector cells
28. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice
29. Activation of macrophages for destruction of Francisella tularensis: Identification of cytokines, effector cells, and effector molecules
30. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production
31. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide
32. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene
33. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis
34. Effect of poloxamer of CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages
35. Effector functions of activated macrophages against parasites
36. Immunobiology of Mycobacterium avium infection
37. Role of nitric oxide in parasitic infections
38. DNA vaccines: Immunology, application, and optimization
39. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
40. Distribution fate and mechanism of immune modulation following muscosal delivery of plasmid DNA encoding IL-10
41. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10
42. Human tumor necrosis factor receptor (p65) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses
43. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity
44. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity
45. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
46. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity
47. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme